A Prospective Radiostereometric Analysis (RSA) and Clinical Evaluation of the Triathlon Tritanium Total Knee Replacement
- Conditions
- Osteoarthritis of the Knee
- Registration Number
- NCT02373761
- Lead Sponsor
- Scott Sporer
- Brief Summary
This study seeks to find out if the tibial and patellar components of the Stryker Triathlon Tritanium primary total knee replacement achieve adequate fixation to the underlying bone.
- Detailed Description
Primary Hypothesis:
The investigators expect the tibial and patellar components of the Stryker Triathlon Tritanium knee to achieve adequate fixation to the underlying bone.
Secondary Hypotheses:
The investigators expect that there will be no continuous migration between one and two years post-operative in the Triathlon Tritanium components.
The investigators expect to see a correlation between radiolucent lines and migration characteristics using RSA.
The investigators expect that inducible displacement exams taken at 2 years post-operative will be able to distinguish between patients identified by RSA measurements as having inadequate fixation.
The investigators expect to see a significant difference in health status and functional outcomes before and after total knee replacement using the Triathlon Tritanium knee.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 27
- Symptomatic osteoarthritis of the knee indicating surgical intervention
- Scheduled to undergo a total knee arthroplasty
- Patients between the ages of 18 and 80, inclusive
- Patient is a candidate for Triathlon Tritanium cementless knee components implanted in accordance with product labeling
- Significant co-morbidity affecting ability to ambulate
- Prior arthroplasty, patellectomy or osteotomy with the affected knee
- Active or prior infection of the affected knee
- Morbid obesity (BMI > 40)
- Medical condition precluding major surgery
- Severe osteoporosis
- Neuromuscular impairment
- Pregnancy
- Inability to give informed consent
- Inability to return for follow-up visits for a minimum of two years after surgery
- Currently participating in any other surgical intervention study
- Known allergy to metals
- Flexion contracture greater than 15°
- Extension lag greater than 10°
- Tibial subluxation greater than 10 mm on standing AP radiograph
- Lateral or medial collateral ligament instability (> 10° varus/valgus)
- Leg length discrepancy greater than 10 mm
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Radiostereometric analysis of tibial and patellar components of the Stryker Triathlon Tritanium at 6 weeks, 3 months, 6 months, 1 year and 2 years. 3 years
- Secondary Outcome Measures
Name Time Method Improved health status and functional outcomes as measured by the Knee Society Scoring System and EQ-5D questionnaires. 3 years
Trial Locations
- Locations (1)
Central DuPage Hospital
🇺🇸Winfield, Illinois, United States